drugset / Trial / NCT02650791
Platelet Transfusion Requirements in Hematopoietic Transplantation Pilot Study
RandomizedParallel-groupOpen-labelOther
Summary
It is hypothesized that a strategy using prophylactic oral Tranexamic Acid (TXA) with therapeutic platelet transfusions is safe and effective compared to prophylactic platelet transfusions in patients undergoing an autologous hematopoietic stem cell transplantation (who are at risk for bleeding).
Timeline
- Start
- 2016-10
- Primary completion
- 2019-06
- Completion
- 2019-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tranexamic Acid | Small molecule | 1 g | Oral |